Vascular diseases and old age mental disorders: An update of neuroimaging findings

Current Opinion in Psychiatry

Volumn 23, Issue 6, 2010, Pages 491-497

  De Toledo Ferraz Alves, Tĝnia C ^a,b   Ferreira, Luiz K ^a   Busatto, Geraldo F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ABC Region Medical School   (Brazil)

Author keywords

Aging; bipolar disorder; brain imaging; dementia; depression; MRI; PET; single photon emission computed tomography; vascular disorders

Indexed keywords

ALZHEIMER DISEASE; BIPOLAR DISORDER; BRAIN REGION; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MENTAL DISEASE; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SENESCENCE; SMOKING HABIT; STROKE; WHITE MATTER;

AGED; BRAIN; CARDIOVASCULAR DISEASES; HUMANS; LEUKOENCEPHALOPATHIES; MENTAL DISORDERS; MOOD DISORDERS;

EID: 77958171640     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32833e339c     Document Type: Review

References (110)

1. de Toledo Ferraz Alves TC, Ferreira LK, Wajngarten M, Busatto GF. Cardiac disorders as risk factors for Alzheimer's disease. J Alzheimers Dis 2010; 20:749-763.
2. Terribli D, Schaufelberger MS, Duran FLS, et al. Age-related gray matter volume changes in the brain during nonelderly adulthood, Neurobiol Aging (in press). doi: 10.1016/j.neurobiolaging.2009.02.008.
3. Curiati PK, Tamashiro JH, Squarzoni P, et al. Brain structural variability due to aging and gender in cognitively healthy Elders: results from the Sao Paulo Ageing and Health study. AJNR Am J Neuroradiol 2009; 30:1850-1856.
4. Enzinger C, Fazekas F, Matthews PM, et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005; 64:1704-1711.
5. Chen X, Wen W, Anstey KJ, Sachdev PS. Effects of cerebrovascular risk factors on gray matter volume in adults aged 60-64 years: a voxel-based morphometric study. Psychiatry Res 2006; 147:105-114.
6. Raz N, Rodrigue KM, Haacke EM. Brain aging and its modifiers: insights from in vivo neuromorphometry and susceptibility weighted imaging. Ann N Y Acad Sci 2007; 1097:84-93.
7. Beason-Held LL, Moghekar A, Zonderman AB, et al. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 2007; 38:1766-1773.
8. Korf ES, White LR, Scheltens P, Launer LJ. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 2004; 44:29-34.
9. Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging 2000; 21:57-62.
10. Jack CR Jr, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998; 51:993-999.
11. Fellgiebel A, Wille P, MullerMJ. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 2004; 18:101-108.
12. Le DS, Chen K, Pannacciulli N, et al. Reanalysis of the obesity-related attenuation in the left dorsolateral prefrontal cortex response to a satiating meal using gyral regions-of-interest. J Am Coll Nutr 2009; 28:667-673.
13. Page KA, Arora J, Qiu M, et al. Small decrements in systemic glucose provoke increases in hypothalamic blood flow prior to the release of counterregulatory hormones. Diabetes 2009; 58:448-452.
14. Kaplar M, Paragh G, Erdei A, et al. Changes in cerebral blood flow detected by SPECT in type 1 and type 2 diabetic patients. J Nucl Med 2009; 50:1993-1998.
15. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008; 24:353-363.
16. Yuen N, Anderson SE, Glaser N, et al. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes 2008; 57:2588-2594.
17. Tsukuda K, Mogi M, Li JM, et al. Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine. Hypertension 2008; 51:528-533.
18. Simons LA, Simons J, Friedlander Y, McCallum J. A comparison of risk factors for coronary heart disease and ischaemic stroke: the Dubbo study of Australian elderly. Heart Lung Circ 2009; 18:330-333.
19. Henon H, Godefroy O, Lucas C, et al. Risk factors and leukoaraiosis in stroke patients. Acta Neurol Scand 1996; 94:137-144.
20. Kim IC, Hur SH, Park NH, et al. Incidence and predictors of silent embolic cerebral infarction following diagnostic coronary angiography. Int J Cardiol (in press). doi: 10.1016/j.ijcard.2009.10.053.
21. Habek M, Ozretic D, Zarkovic K, et al. Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis. Neurol Sci 2009; 30: 45-49.
22. Ettorre E, Cicerchia M, De Benedetto G, et al. A possible role of atrial fibrillation as a risk factor for dementia. Arch GerontolGeriatr 2009; 49 (Suppl 1):71-76.
23. Ohsawa N, Takahashi S, Yonezawa H. Cerebral blood flow patterns in patients with leukoaraiosis and lacunar infarction [in Japanese]. Rinsho Shinkeigaku 1994; 34:443-448.
24. Wozakowska-Kaplon B, Opolski G, Kosior D, et al. Cognitive disorders in elderly patients with permanent atrial fibrillation. Kardiol Pol 2009; 67:487-493.
25. Puccio D, Novo G, Baiamonte V, et al. Atrial fibrillation and mild cognitive impairment: what correlation? Minerva Cardioangiol 2009; 57:143-150.
26. Peters R, Poulter R, Beckett N, et al. Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial. J Hypertens 2009; 27:2055-2062.
27. Knecht S, Oelschlager C, Duning T, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J 2008; 29:2125-2132.
28. Zambroski CH. Qualitative analysis of living with heart failure. Heart Lung 2003; 32:32-40.
29. Vogels RL, Oosterman JM, van Harten B, et al. Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 2007; 24:418-423.
30. Vogels RL, van der Flier WM, van Harten B, et al. Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 2007; 9:1003-1009.
31. Gruhn N, Larsen FS, Boesgaard S, et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001; 32:2530-2533.
32. Almeida OP, Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001; 31:290-295.
33. Alves TC, Rays J, Fraguas R Jr, et al. Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT. J Neuroimaging 2005; 15:150-156.
34. Georgiadis D, Sievert M, Cencetti S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J 2000; 21:407-413.
35. Lassen NA, Larsen OA. Measurement of blood flow with freely diffusible indicators as inert gases, antipyrine, labelled water and rubidium. Acta Endocrinol Suppl (Copenh) 1972; 158:95-111.
36. Alves TC, Busatto GF. Regional cerebral blood flow reductions, heart failure and Alzheimer's disease. Neurol Res 2006; 28:579-587.
37. Alves TC, Rays J, Fraguas R Jr, et al. Association between major depressive symptoms in heart failure and impaired regional cerebral blood flow in the medial temporal region: a study using 99m Tc-HMPAO single photon emission computerized tomography (SPECT). Psychol Med 2006; 36:597-608.
38. Zivadinov R, Weinstock-Guttman B, Hashmi K, et al. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 2009; 73:504-510.
39. McClernon FJ. Neuroimaging of Nicotine Dependence: Key Findings and Application to the Study of Smoking-Mental Illness Comorbidity. J Dual Diagn 2009; 5:168-178.
40. Friedman L, Turner JA, Stern H, et al. Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls. Neuroimage 2008; 40:1181-1194.
41. Brody AL, Mandelkern MA, Jarvik ME, et al. Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol 2009; 12:305-316.
42. Brody AL, Mandelkern MA, Jarvik ME, et al. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry 2004; 55:77-84.
43. Almeida OP, Garrido GJ, Lautenschlager NT, et al. Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease. Am J Geriatr Psychiatry 2008; 16:92-98.
44. Azizian A, Monterosso J, O'Neill J, London ED. Magnetic resonance imaging studies of cigarette smoking. Handb Exp Pharmacol 2009; (192):113-143.
45. Ong CT, Sung KC, Sung SF, et al. Impact of silent infarction on the outcome of stroke patients. J Formos Med Assoc 2009; 108:224-230.
46. Kwon HM, Kim BJ, Park JH, et al. Significant association of metabolic syndrome with silent brain infarction in elderly people. J Neurol 2009; 256:1825-1831.
47. Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2009; 40:1229-1236.
48. Tiemeier H. Biological risk factors for late life depression. Eur J Epidemiol 2003; 18:745-750.
49. Krishnan KR. Biological risk factors in late life depression. Biol Psychiatry 2002; 52:185-192.
50. Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008; 39:397-402.
51. Menon U, Kelley RE. Subcortical ischemic cerebrovascular dementia. Int Rev Neurobiol 2009; 84:21-33.
52. Yakushiji Y, Nishiyama M, Yakushiji S, et al. Brain microbleeds and global cognitive function in adults without neurological disorder. Stroke 2008; 39:3323-3328.
53. van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 2008; 39:2712-2719.
54. Peters N, Holtmannspotter M, Opherk C, et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology 2006; 66:1517-1522.
55. Chui HC. Subcortical ischemic vascular dementia. Neurol Clin 2007; 25:717-740; vi.
56. Singhal S, Bevan S, Barrick T, et al. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004; 127 (Pt 9):2031-2038.
57. Soderlund H, Nyberg L, Adolfsson R, et al. High prevalence of white matter hyperintensities in normal aging: relation to blood pressure and cognition. Cortex 2003; 39:1093-1105.
58. de Leeuw FE, de Groot JC, Oudkerk M, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002; 125 (Pt 4):765-772.
59. de Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004; 35:1057-1060.
60. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010; 41:600-606.
61. Iosifescu DV, Renshaw PF, Lyoo IK, et al. Brain white-matter hyperintensities and treatment outcome in major depressive disorder. Br J Psychiatry 2006; 188:180-185.
62. Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004; 35:1857-1861.
63. Markus HS, Hunt B, Palmer K, et al. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke 2005; 36:1410-1414.
64. Murray AD, Staff RT, Shenkin SD, et al. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005; 237:251-257.
65. Gouw AA, Seewann A, Vrenken H, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: postmortem quantitative MRI and neuropathology. Brain 2008; 131 (Pt 12):3286-3298.
66. Kraut MA, Beason-Held LL, Elkins WD, Resnick SM. The impact of magnetic resonance imaging-detected white matter hyperintensities on longitudinal changes in regional cerebral blood flow. J Cereb Blood Flow Metab 2008; 28:190-197.
67. Venkatraman VK, Aizenstein H, Guralnik J, et al. Executive control function, brain activation and white matter hyperintensities in older adults. Neuroimage 2010; 49:3436-3442.
68. Wen W, Sachdev PS, Chen X, Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 2006; 29:1031-1039.
69. Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 2008; 79:619-624.
70. Tamashiro JH, Zung S, Zanetti MV, et al. Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord 2008; 10:765-775.
71. Zanetti MV, Cordeiro Q, Busatto GF. Late onset bipolar disorder associated with white matter hyperintensities: a pathophysiological hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:551-556.
72. Teodorczuk A, O'Brien JT, Firbank MJ, et al. White matter changes and latelife depressive symptoms: longitudinal study. Br J Psychiatry 2007; 191:212-217.
73. Pompili M, Ehrlich S, De Pisa E, et al. White matter hyperintensities and their associations with suicidality in patients with major affective disorders. Eur Arch Psychiatry Clin Neurosci 2007; 257:494-499.
74. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005; 36:56-61.
75. Kohler S, Thomas AJ, Lloyd A, et al. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry 2010; 196:143-149.
76. Regenold WT, Hisley KC, Phatak P, et al. Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients. Bipolar Disord 2008; 10:753-764.
77. Delano-Wood L, Abeles N, Sacco JM, et al. Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 2008; 39:794-799.
78. Jonsson M, Edman A, Lind K, et al. Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia. Int J Geriatr Psychiatry 2010; 25:588-595.
79. Alexopoulos GS, Meyers BS, Young RC, et al. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997; 54:915-922.
80. Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression. Am J Psychiatry 1997; 154:562-565.
81. Teper E, O'Brien JT. Vascular factors and depression. Int J Geriatr Psychiatry 2008; 23:993-1000.
82. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care 1993; 16:1167-1178.
83. Jones-Webb R, Jacobs DR Jr, Flack JM, Liu K. Relationships between depressive symptoms, anxiety, alcohol consumption, and blood pressure: results from the CARDIA Study. Coronary Artery Risk Development in Young Adults Study. Alcohol Clin Exp Res 1996; 20:420-427.
84. Thomas AJ, Kalaria RN, O'Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord 2004; 79:81-95.
85. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005; 36:1330-1340.
86. Liebetrau M, Steen B, Skoog I. Depression as a risk factor for the incidence of first-ever stroke in 85-year-olds. Stroke 2008; 39:1960-1965.
87. Luijendijk HJ, Tiemeier H, van den Berg JF, et al. Heart failure and incident late-life depression. J Am Geriatr Soc 2010 [Epub ahead of print].
88. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a metaanalytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48:1527-1537.
89. Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21:30-38.
90. Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998; 158:1422-1426.
91. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66:814-822.
92. Alexopoulos GS. Depression in the elderly. Lancet 2005; 365:1961-1970.
93. Almeida JR, Alves TC, Wajngarten M, et al. Late-life depression, heart failure and frontal white matter hyperintensity: a structural magnetic resonance imaging study. Braz J Med Biol Res 2005; 38:431-436.
94. Andreescu C, Butters MA, Begley A, et al. Gray matter changes in late life depression: a structural MRI analysis. Neuropsychopharmacology 2008; 33:2566-2572.
95. Ballmaier M, Toga AW, Blanton RE, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRIbased parcellation of the prefrontal cortex. Am J Psychiatry 2004; 161:99-108.
96. Kumar A, Thomas A, Lavretsky H, et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 2002; 159:630-636.
97. Mast BT, Yochim B, MacNeill SE, Lichtenberg PA. Risk factors for geriatric depression: the importance of executive functioning within the vascular depression hypothesis. J Gerontol A Biol Sci Med Sci 2004; 59:1290-1294.
98. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64:543-552.
99. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord 2004; 6:343-367.
100. Börnke C, Postert T, Przuntek H, Büttner T. Acute mania due to a right hemisphere infarction. Eur J Neurol 1998; 4:407-409.
101. Goyal R, Sameer M, Chandrasekaran R. Mania secondary to right-sided stroke-responsive to olanzapine. Gen Hosp Psychiatry 2006; 28:262-263.
102. da Rocha FF, Correa H, Teixeira AL. A successful outcome with valproic acid in a case of mania secondary to stroke of the right frontal lobe. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:587-588.
103. Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry 1989; 154:170-182.
104. Wijeratne C, Malhi GS. Vascular mania: an old concept in danger of sclerosing? A clinical overview. Acta Psychiatr Scand Suppl 2007; (434):35-40.
105. Mahon K, Burdick KE, Szeszko PR. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev 2010; 34:533-554.
106. Kempton MJ, Geddes JR, Ettinger U, et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65:1017-1032.
107. Bastos-Leite AJ, Kuijer JP, Rombouts SA, et al. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008; 29:1296-1301.
108. Firbank MJ, Minett T, O'Brien JT. Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects. Neurology 2003; 61:950-954.
109. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004; 63:246-253.
110. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43:705-712.